Hong Kong Chief Executive John Lee visits Qingsong Health's tech exhibition, focusing on AI evidence-based medicine and early screening.

The 2026 World Internet Conference Asia-Pacific Summit, hosted by the World Internet Conference and organized by the Hong Kong Special Administrative Region Government, opened at the Hong Kong Convention and Exhibition Centre. With the theme of digital intelligence empowerment and innovation development, the summit brought together global political and business leaders, international organization representatives and industry experts to discuss artificial intelligence safety governance, AI agent innovation and application, digital finance, digital health and other frontier topics.

Qingsong Health Group (2661.HK) appeared at the summit with its evidence-based medical agent QSevidence MedClaw and a matrix of early disease screening products, presenting the group's technological progress and application practices in AI plus health.

The World Internet Conference is a global high-level dialogue platform initiated by China for the internet sector. Since 2014, it has become one of the most influential international summits for internet governance and digital economy development. The Asia-Pacific Summit, the conference's flagship activity for the region, attracted nearly one thousand senior representatives from more than 50 countries and regions. Hong Kong Chief Executive John Lee, heads of central government agencies in Hong Kong and guests from many sectors attended the opening ceremony.

During the opening ceremony, Hong Kong Chief Executive John Lee, Zhuang Rongwen, Director of the Cyberspace Administration of China and Chairman of the World Internet Conference, and Zhou Ji, Director of the Liaison Office of the Central People's Government in the Hong Kong Special Administrative Region and National Security Affairs Adviser to the Hong Kong SAR Committee for Safeguarding National Security, visited the Qingsong Health booth. The group's representatives introduced QSevidence's evidence-based medical decision support capabilities, the standardized clinical skill system of MedClaw Skills Store, and the implementation results of early screening products in disease prevention.

The leaders paid close attention to Qingsong Health's innovation in medical AI and learned in depth how artificial intelligence technology can better serve people's health.

As one of the group's core AI products launched this year, QSevidence is designed around evidence-based medicine methodology and serves real clinical scenarios by providing doctors with explainable, verifiable and traceable medical decision support. Unlike medical AI products based mainly on general large models, QSevidence embeds an evidence-based medicine system at the architecture level. Evidence first and source traceability are native capabilities, and each answer marks the clinical guidelines, literature sources and evidence levels on which it is based, helping reduce AI hallucination risk from the mechanism level.

In professional benchmarks, QSevidence achieved a 100% correct rate on the CMB2023 Chinese National Medical Licensing Examination, becoming the first AI system in China to achieve a perfect score on a national medical examination. It also achieved state-of-the-art performance in higher-difficulty senior and associate-senior oncology examinations, outperforming multiple comparable products. QSevidence has built a knowledge foundation covering more than 50 million authoritative Chinese and English medical data records, has worked with more than 3,000 professional doctors in model training, and has launched MedClaw Skills Store with an initial release of 886 standardized skills covering clinical diagnosis and treatment, public health and other fields.

Based on its self-developed AIcare technology stack, Qingsong Health has also built an early screening portfolio around the idea of early screening, early diagnosis and early treatment. The portfolio covers liver health, intestinal health, bone health, women's three-cancer screening and other common disease areas. Through AI-driven full-process health management services, users can complete early screening appointments, report interpretation and follow-up health consultation through online platforms, creating a one-stop service loop from prevention to rehabilitation.

The summit took advantage of Hong Kong's unique position connecting China and the world, creating a high-level platform for international exchange and cooperation in digital intelligence technologies. As a Hong Kong-listed health technology company, Qingsong Health will use the summit as an opportunity to deepen R&D and implementation of medical AI technologies, drive the upgrade of public health management through technology innovation, and contribute to high-quality development of the digital health industry in the Asia-Pacific region.

Original source: https://www.qingsonghealth.com/show-86.html